HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The clinical spectrum of laryngeal dystonia includes dystonic cough: observations of a large series.

Abstract
Laryngeal dystonia is a movement disorder of the muscles within the larynx, which most commonly manifests as spasmodic dysphonia (SD). Rarer reported manifestations include dystonic respiratory stridor and dyscoordinate breathing. Laryngeal dystonia has been treated successfully with botulinum neurotoxin (BTX) injections since 1984. We reviewed prospectively collected data in a consecutive series of 193 patients with laryngeal dystonia who were seen at St. Vincent's Hospital between 1991 and 2011. Patient data were analyzed in Excel, R, and Prism. Laryngeal dystonia manifested as SD (92.7%), stridor (11.9%), dystonic cough (6.2%), dyscoordinate breathing (4.1%), paroxysmal hiccups (1.6%), and paroxysmal sneezing (1.6%). There were more women (68.4%) than men (31.6%), and the average age at onset was 47 years. A positive family history of dystonia was present in 16.1% of patients. A higher incidence of extra-laryngeal dystonia (ie, torticollis and blepharospasm) and concurrent manifestations of laryngeal dystonia were present in patients with dystonic cough, dyscoordinate breathing, paroxysmal sneezing, and hiccups than in other patients (P = 0.003 and P < 0.0001, respectively). The average starting dose of BTX decreased from 2.3 to 0.5 units between 1991 and 2011. The median treatment rating was excellent across all subgroups. Patients with adductor SD, stridor, extra-laryngeal dystonia and male patients had relatively better treatment outcomes. Technical failures were rare (1.1%). Dysphonia secondary to vocal cord paresis followed 38.7% of treatments. Laryngeal dystonia manifests predominantly as SD, but other manifestations include stridor, dyscoordinate breathing, paroxysmal cough, hiccups, and sneezing. BTX injections are very effective across all subgroups. Severe adverse events are rare.
AuthorsSusannah Payne, Stephen Tisch, Ian Cole, Helen Brake, Judy Rough, Paul Darveniza
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 29 Issue 6 Pg. 729-35 (May 2014) ISSN: 1531-8257 [Electronic] United States
PMID24753288 (Publication Type: Journal Article)
Copyright© 2014 International Parkinson and Movement Disorder Society.
Chemical References
  • Neurotoxins
  • Botulinum Toxins
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Botulinum Toxins (therapeutic use)
  • Cough (drug therapy, etiology)
  • Dystonia (classification, complications, drug therapy)
  • Female
  • Humans
  • Laryngeal Diseases (complications, drug therapy)
  • Linear Models
  • Male
  • Middle Aged
  • Neurotoxins (therapeutic use)
  • Observation
  • Retrospective Studies
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: